Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
19 sept. 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
VitalCaring’s AI-driven Cognitive Care Pilot Shows Promising Results
12 sept. 2024 07h26 HE
|
Constant Therapy Health; VitalCaring
VitalCaring’s AI-driven cognitive care pilot shows statistically significant cognitive improvements. Provider to extend initiative across its network.
Author Sonya Jury Shares Life Lessons in Her New Book Mom Forgot My Birthday: A Daughter’s Journey Through Alzheimer’s
26 août 2024 07h00 HE
|
Sonya Jury, Author
Sonya Jury shares her lessons as a caregiver in her book, "Mom Forgot My Birthday: A Daughter’s Journey Through Alzheimer’s."
Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
06 août 2024 09h00 HE
|
FN Media Group LLC
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to a report from Mordor Intelligence, the Alzheimer's Disease Diagnostics And Therapeutics Market size...
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
06 août 2024 08h30 HE
|
FN Media Group LLC
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of...
ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults
29 juil. 2024 07h45 HE
|
ZyVersa Therapeutics
Plasma levels of inflammasome ASC show promise as a biomarker of early cognitive decline in older adults.
Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy
03 juin 2024 10h35 HE
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NIKA) introduces its business strategy that should generate a net profit of more than 1 billion USD by the end of 2025.
Inaugural Dementia Conference in Africa, Convened by Nature, Davos Alzheimer’s Collaborative, and Aga Khan University, to Advance Lifespan Brain Health Innovations Across Diverse Communities
16 mai 2024 08h54 HE
|
Davos Alzheimer's Collaborative
Geneva, Switzerland, May 16, 2024 (GLOBE NEWSWIRE) -- Researchers, policymakers, and industry leaders from the global south will convene to showcase Africa’s unique brain health and dementia...
Global Psychiatry Collaboration and Licensing Deals Directory, 2019-2024: Deal Trends, Leading Deals by Value, Most Active Dealmakers, Financials Terms, and More
26 avr. 2024 10h16 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Psychiatry Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Psychiatry Collaboration and...
Unlocking the Secrets to a Sharper Mind and Healthier Cells
17 avr. 2024 09h00 HE
|
Return Healthy
St. George, Utah, April 17, 2024 (GLOBE NEWSWIRE) -- In an era of rising health concerns, particularly those affecting cognitive functions, Return Healthy reveals its groundbreaking Cell...